Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9936322 | 0.90 | HPGD (0.34) | CTDSP1 | |
| SCHEMBL18526268 | 0.90 | CTDSP1 (0.33) | CTDSP1 | |
| SCHEMBL2100281 | 0.90 | CTDSP1 (0.44) | CTDSP1 | |
| SCHEMBL575287 | 0.88 | CHRNA7 (0.37) | CTDSP1CHRNA7 | |
| Iodide SCHEMBL9179010 | 0.87 | CTDSP1 (0.46) | CTDSP1 | |
| Bromide SCHEMBL28941734 | 0.87 | CTDSP1 (0.42) | CTDSP1 | |
| Iodide SCHEMBL9011443 | 0.86 | CTDSP1 (0.36) | CTDSP1CHRNA7 | |
| Bromide SCHEMBL19439575 | 0.86 | CHRNA7 (0.35) | CTDSP1CHRNA7 | |
| SCHEMBL4905084 | 0.85 | CTDSP1 (0.35) | CTDSP1 | |
| SCHEMBL2859463 | 0.85 | CDC25A (0.35) | CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | CTDSP1 1265/4885CHRNA7 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.